Ultrasound Still Underused for Initial Imaging of Acute Renal Colic
Initial ultrasound imaging of emergency department patients presenting with acute renal colic, although increasing, was used in only 6.9% of cases in 2015.
Diagnosis & Disease Information
Clinical Variables Predict Radiographic Progression in mCRPC
Extent of disease and change in PSA were the strongest predictors of disease progression in men with chemotherapy-naïve mCRPC treated with abiraterone.
Neoadjuvant vs Adjuvant Chemo Ups MIBC Patient Survival
The 5-year overall survival rate is significantly higher among radical cystectomy patients who receive neoadjuvant vs adjuvant chemotherapy, study finds.
Aspirin Use Prior to Radical Cystectomy Linked to Improved Survival
Daily use of aspirin before radical cystectomy is associated with a significant 36% and 30% decreased risk of cancer-specific and all-cause mortality.
Delayed mRCC Targeted Therapy Does Not Worsen Survival
In a study of mRCC patients who received targeted therapy (TT) following cytoreductive nephrectomy, mortality risk did not differ significantly between delayed and early TT.
Racial Disparities in RCC Survival Driven by Socioeconomic Factors
Black patients tended to have lower incomes, less education, longer delays to treatment, greater comorbidity burden.
AUA Issues New Surgical Treatment Guidelines for LUTS
New clinical guidelines for the surgical management of lower urinary tract symptoms attributable to enlarged prostate offer 22 recommendations.
Focal vs Total PCa Cryoablation Better for Sexual Function
Oncologic outcomes are similar for focal and total cryoablation for localized prostate cancer, but patients report significantly better sexual function after focal cryoablation.
Stone Composition Linked to Race, Ethnicity
Compared with whites, blacks, and Hispanics, Middle Easterners are more likely to have predominantly calcium oxalate monohydrate stones, but less likely to have hydroxyapatite stones.
Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk
Men on active surveillance for prostate cancer who had a negative confirmatory biopsy experienced an 88% decreased risk of progression to treatment.
- Loading...
Loading...
Next post in AUA 2018 Coverage
Loading... 
Loading...